Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related XOMA
Morning Market Gainers
Benzinga's Top #PreMarket Gainers
XOMA: Phase 3 EYEGUARD-B Trial Is Good News For Gevokizumab (Seeking Alpha)
Related FMC
Must Watch Stocks for May 11, 2015
Earnings Scheduled For May 11, 2015
Larry Robbins' New Buys During Q1 2015 (GuruFocus)

Analysts at McNicoll Lewis Valk downgraded XOMA (NASDAQ: XOMA) from “buy” to “hold.” The price target for XOMA has been lowered from $8 to $7. XOMA's shares closed at $6.43 yesterday.

Wells Fargo downgraded FMC (NYSE: FMC) from “outperform” to “market perform.” FMC's shares closed at $83.10 yesterday.

Analysts at Goldman Sachs downgraded Vipshop Holdings (NYSE: VIPS) from “buy” to “neutral.” The price target for Vipshop has been raised from $84.20 to $185. Vipshop's shares closed at $158.48 yesterday.

Keefe Bruyette & Woods downgraded U.S. Bancorp (NYSE: USB) from “outperform” to “market perform.” U.S. Bancorp's shares closed at $42.35 yesterday.

Latest Ratings for XOMA

DateFirmActionFromTo
May 2015Credit SuisseAssumesNeutral
Mar 2015Ladenburg ThalmannUpgradesNeutralBuy
Nov 2014Ladenburg ThalmannDowngradesBuyNeutral

View More Analyst Ratings for XOMA
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (FMC + USB)

Around the Web, We're Loving...

Get Benzinga's Newsletters